Piramal Pharma Share Price

Small Cap | Pharmaceuticals and health care | NSE: PPLPHARMA | BSE: 543635

₹204.35 image-16.75 (-7.58 %)

Last Updated: 11 Feb 2025 04:01 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 220.15

High (₹) 221.50

Low (₹) 203.10

Prev. Close (₹) 221.10

Volume 2,03,297

VWAP (₹) 228.16

ROCE (%) 5.76

Industry P/E 47.86

TTM P/E 704.66

P/B Ratio 3.42

Market Cap (₹) Cr.27,082.38

Dividend Yield (%)0.05

EPS (₹) 0.14

ROE0.23%

Sales Growth (%) 15.39

Profit Growth (%)-82.69

Day Range

221.50221.50

L
H

52 Week Range

114.45307.85

L
H

Historical Returns

Returns (6M)

12.25 %

Returns (1Y)

52.96 %

Returns (3Y)

9.12 %

Returns (5Y)

9.12 %

Returns (6M)

12.25 %

Returns (1Y)

52.96 %

Returns (3Y)

9.12 %

Returns (5Y)

9.12 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Increasing Annual Revenue for Past 2 Years
  • Positive ROC (9) indicates upward momentum.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 54.57

MFI 54.15

ATR 12.39

Commodity Channel Index -82.88

ROC125 22.53

ROC21 -7.64

Williams %R -53.29

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current231.69236.82240.64227.87222.74218.92213.79
Week Ago237.49242.07245.34234.22229.64226.37221.79
Month Ago253.26256.18258.96250.48247.56244.78241.86

EMA & SMA
info_icon

204.35

Current Price

EMA & SMApin

Bullish Moving Averages

1

Bearish Moving Averages

19

5 Day 229.89


9 Day 232.71


10 Day 227.79


12 Day 231.68


14 Day 232.74

20 Day 232.74


26 Day 237.66


50 Day 247.47


100 Day 244.02


200 Day 204.35

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
EAST BRIDGE CAPITAL MASTER FUND LIMITEDblockSell31 Oct, 2023₹102.803,36,43,099BSE
EAST BRIDGE CAPITAL MASTER FUND I LIMITEDblockBuy31 Oct, 2023₹102.803,36,43,099BSE
EAST BRIDGE CAPITAL MASTER FUND LIMITEDbulkSell31 Oct, 2023₹102.803,36,43,099BSE
EAST BRIDGE CAPITAL MASTER FUND I LIMITEDbulkBuy31 Oct, 2023₹102.803,36,43,099BSE
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell03 Nov, 2022₹166.9540,50,700BSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy03 Nov, 2022₹166.9540,50,700BSE

Insider Trading

No insider trading details available.

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
10 May, 2024Rs.0.1100 per share(1.1%)Final Dividend12 Jul, 202412 Jul, 2024
08 Feb, 2023Rights issue of equity shares of Rs. 10/- in the ratio of 5:46 @ premium of Rs. 71/-.02 Aug, 202302 Aug, 2023

Announcements

DateSourceDetail
31 Jan, 2025NSE IndiaPiramal Pharma Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Extension of timeline communicated for sale of Company s Unit situated at Thane
31 Jan, 2025BSE IndiaIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Extension of timeline communicated for sale of Company''s Unit situated at Thane.
30 Jan, 2025BSE IndiaTranscript of Conference call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2024
30 Jan, 2025NSE IndiaPiramal Pharma Limited has informed the Exchange about Transcript
30 Jan, 2025BSE IndiaTranscript of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2024
29 Jan, 2025NSE IndiaPiramal Pharma Limited has informed the Exchange about Link of Recording
29 Jan, 2025BSE IndiaAudio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2024
29 Jan, 2025NSE IndiaPiramal Pharma Limited has informed the Exchange about Giving guarantees/indemnity/ becoming a surety for third party
29 Jan, 2025BSE IndiaIntimation under Regulation 30 of The Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (\SEBI Listing Regulations\) - Issuance of Corporate Guarantee.
28 Jan, 2025NSE IndiaIntegrated Filing (Financial) for the quarter and nine months ended December 31, 2024

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--14 Jan, 202528 Jan, 2025
Quarterly Results--15 Oct, 202423 Oct, 2024
Quarterly Results--16 Jul, 202426 Jul, 2024
Audited Results & Final Dividend--02 May, 202410 May, 2024
Quarterly Results--18 Jan, 202430 Jan, 2024
Quarterly Results--19 Oct, 202327 Oct, 2023
Quarterly Results--31 Jul, 202303 Aug, 2023
Audited Results--19 May, 202324 May, 2023
Quarterly Results & Rights issue--07 Feb, 202308 Feb, 2023
Quarterly Results--02 Nov, 202208 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Piramal Pharma

Piramal Pharma is a Public Limited Listed company incorporated on 04/03/2020 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U24297MH2020PLC338592 and registration number is 338592. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 4390.11 Cr. and Equity Capital is Rs. 1322.95 Cr. for the Year ended 31/03/2024.  Read More

Parent Organisation

Piramal Ajay Group

Founded

2020

Managing Director

-- --

NSE Symbol

PPLPHARMA

Piramal Pharma Management

NameDesignation
Mrs. Nandini PiramalChairperson
Mr. Vivek ValsarajExecutive Director & CFO
Mr. Peter DeYoungExecutive Director
Mr. Neeraj BharadwajNon Executive Director
Ms. Vibha Paul RishiIndependent Director
Mr. Jairaj PurandareIndependent Director
Mr. Peter StevensonIndependent Director
Mr. S RamadoraiIndependent Director
Mr. Sridhar GorthiIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
SunPhrmInds₹4,46,576.22₹1,699.75 image
₹1,732.10(-1.87%)
₹1,249.800 - ₹1,960.200
Divis Labora₹1,56,123.40₹5,946.75 image
₹5,938.80(0.13%)
₹3,350.050 - ₹6,448.750
Cipla₹1,21,675.13₹1,453.15 image
₹1,458.85(-0.39%)
₹1,240.700 - ₹1,702.000
ManKind Phar₹1,18,478.90₹2,450.30 image
₹2,502.05(-2.07%)
₹1,910.100 - ₹3,050.000
DrReddysLab₹1,15,939.04₹1,209.80 image
₹1,220.95(-0.91%)
₹1,104.690 - ₹1,420.200

FAQs on Piramal Pharma

What is the share price of Piramal Pharma?

The share price of Piramal Pharma on 11 Feb, 2025 is ₹ 204.35.

What is 52W high and 52W low share price of Piramal Pharma?

The highest and lowest 52W share prices of Piramal Pharma are ₹ 307.850 and ₹ 114.450

What is the market cap of Piramal Pharma?

The market capitalization of Piramal Pharma as of 11 Feb, 2025 is ₹ 27,082.38 Crores

What is the P/E ratio of Piramal Pharma?

The current P/E ratio of Piramal Pharma as of 11 Feb, 2025 is 47.86

What is the PB ratio of Piramal Pharma?

The PB ratio of Piramal Pharma as of 11 Feb, 2025 is 3.42

Top Gainers

948IHFL26I

IBHFL NCD186

₹845image

₹705 (0.2%)

GREAVESCOT

Greaves

₹281.85image

₹234.9 (0.2%)

ASHSI

Ashirwd Stl

₹45.66image

₹38.05 (0.2%)

CAPRO

Caprola.Chem

₹62.4image

₹52 (0.2%)

Top Losers

DHANBANK

Dhanalak.Bnk

₹32.19image

₹35.97 (-0.11%)

08MPD

08MPD

₹8.66image

₹9.62 (-0.1%)

BALTE

BalurghtTran

₹27.13image

₹31.24 (-0.13%)

DARSHANORNA

Darshan Orna

₹4.57image

₹5.07 (-0.1%)

Market Indices

Sensex

₹78,699.07image

₹78,472.48 (0%)

Source : Dion Global Solutions Limited